40mg Azimbra, Adalimumab Injection

Azimbra contains adalimumab, a fully human monoclonal antibody that blocks tumor necrosis factor alpha (TNF-??), a key cytokine involved in the pathogenesis of autoimmune diseases such as rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. Azimbra is administered subcutaneously and effectively reduces joint inflammation, pain, and damage. Side effects include increased susceptibility to infections (including tuberculosis), injection site reactions, and possible infusion-related reactions. Patients require screening for latent tuberculosis and close monitoring during treatment. Use in pregnancy or breastfeeding should be under strict medical advice. Prior vaccination and infection history must be reviewed.

Brands available:

1. Exemptia 40mg Injection (ZYDUS CADILA)

2. Mabvinra 40mg Injection (ALKEM LABORATORIES)

3. Plamumab 40mg Injection (CIPLA LTD)

4. Adlumab 40mg Injection (RPG LIFE SCIENCES)

5. Azimbra 40mg Injection (ABBOTT)

6. Adalipca 40mg Injection (IPCA LABORATORIES)

7. Adfrar 40mg Injection (TORRENT PHARMACEUTICALS)

8. Amab 40mg Injection (DR REDDY'S LABORATORIES)

9. Humimab HC 40mg Injection (SUN PHARMACEUTICALS)

10. Adalirel 40mg Injection (RELIANCE LIFE SCIENCES)

11. Bonmiraa 40mg Injection (PHOENIX BIOMED)

12. Mabura 40mg Injection (HETERO HEALTHCARE LTD)